Table 2.
Statistical analysis of demographic/clinical data and CVST characteristics between patients with good (mRS = 0–1) and bad (mRS = 2–6) outcomes.
| mRS 0–1 (n = 26) | mRS 2–6 (n = 4) | p value | |||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Gender | 1.000 | ||||
| female | 14 | (53.8%) | 2 | (50.0%) | |
| male | 12 | (46.2%) | 2 | (50.0%) | |
| Age (yrs) | 40.00 | (33.50–48.50) | 69.50 | (33.50–86.00) | 0.082 |
| Risk Factors | 0.659 | ||||
| coagulation dysfunction | 9 | (34.6%) | 1 | (25.0%) | |
| autoimmune diseases | 4 | (15.4%) | 1 | (25.0%) | |
| malignancy | 1 | (3.8%) | 1 | (25.0%) | |
| idiopathic | 8 | (30.8%) | 1 | (25.0%) | |
| pregnancy | 1 | (3.8%) | 0 | (0.0%) | |
| medications | 3 | (11.5%) | 0 | (0.0%) | |
| Symptoms & Signs | |||||
| headaches | 21 | (80.8%) | 2 | (50.0%) | 0.225 |
| seizures | 5 | (19.2%) | 2 | (50.0%) | 0.225 |
| focal deficits | 11 | (42.3%) | 3 | (75.0%) | 0.315 |
| Onset to Diagnosis (day) | 3.00 | (2.00–7.25) | 3.50 | (2.25–6.25) | 0.877 |
| initial mRS | 2.00 | (1.00–3.00) | 5.00 | (4.25–5.00) | 0.003** |
| initial GCS | 15.00 | (14.00–15.00) | 11.00 | (5.00–11.75) | 0.004** |
| Length of Hospitalization (day) | 14.00 | (8.75–18.25) | 20.00 | (10.75–28.50) | 0.221 |
| Initial ICH size | 0.188 | ||||
| nil | 18 | (69.2%) | 1 | (25.0%) | |
| <3 cm | 4 | (15.4%) | 2 | (50.0%) | |
| ≧3 cm | 4 | (15.4%) | 1 | (25.0%) | |
| Location of Thrombosis& | |||||
| SSS | 9 | (34.6%) | 4 | (100.0%) | 0.026* |
| TS | 18 | (69.2%) | 1 | (25.0%) | 0.126 |
| SiS | 7 | (26.9%) | 0 | (0.0%) | 0.548 |
| StS | 1 | (3.8%) | 0 | (0.0%) | 1.000 |
| cortical veins | 13 | (50.0%) | 3 | (75.0%) | 0.602 |
| CVST Configurations | 0.644 | ||||
| type A | 2 | (7.7%) | 0 | (0.0%) | |
| type B | 11 | (42.3%) | 1 | (25.0%) | |
| type C | 2 | (7.7%) | 0 | (0.0%) | |
| type D | 11 | (42.3%) | 3 | (75.0%) | |
| Length of Thrombosis (cm) | 8.02 | (4.73–9.90) | 14.75 | (11.13–20.07) | 0.009** |
| Length Group | 0.008** | ||||
| <10 | 17 | (77.3%) | 0 | (0.0%) | |
| ≥10 | 5 | (22.7%) | 4 | (100.0%) | |
| Recanalization# (MR at 3 mo f/u) | 0.235 | ||||
| failed | 2 | (8.3%) | 1 | (33.3%) | |
| partial | 12 | (50.0%) | 2 | (66.7%) | |
| complete | 10 | (41.7%) | 0 | (0.0%) | |
Chi-square test. Mann-Whitney U test, Median (IQR). *p < 0.05, **p < 0.01.
&Two or more sinuses were involved in 12 patients, so the sums of the percentages were more than 100%.
#Three patients in I/S group did not have MR study at 3 months follow-up.
abbreviations: sigmoid sinus = SiS; straight sinus = StS; superior sagittal sinus = SSS; transverse sinus = TS.